Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 28, 2015; 21(16): 4933-4945
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.4933
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.4933
Table 4 Characteristics of hepatocellular carcinoma patients with hepatitis C virus infection
Variables | All patients (n = 100) | LL group (n = 34) | HL group (n = 39) | HH group (n = 27) | P value |
Age (yr) | 71 (62-77) | 72 (64-77) | 70 (62-75) | 70 (65-77) | 0.766 |
Sex, male/female | 82/18 | 22/12 | 29/10 | 16/11 | 0.413 |
Body mass index | 23.6 ± 3.6 | 23.6 ± 2.9 | 23.8 ± 3.8 | 23.4 ± 4.1 | 0.737 |
Open/Pure Lap/Lap-assisted | 77/12/11 | 26/3/5 | 27/8/4 | 24/1/2 | 0.218 |
Hr | |||||
0/S/1/2/3 | 57/27/11/2/3 | 23/8/3/0/0 | 21/10/5/1/2 | 13/9/3/1/1 | 0.784 |
Preoperative laboratory values | |||||
Aspartate transaminase (U/L) | 47 (30-64) | 41 (23-56) | 48 (35-67) | 53 (47-71) | 0.101 |
Alanine transaminase (U/L) | 38 (26-57) | 33 (21-53) | 41 (28-57) | 42 (29-62) | 0.496 |
Platelets (× 104/μL) | 13.5 ± 6.8 | 13.9 ± 4.7 | 13.9 ± 9.2 | 12.5 ± 4.4 | 0.804 |
Serum ALB (g/dL) | 3.76 ± 0.39 | 3.94 ± 0.40 | 3.67 ± 0.35 | 3.67 ± 0.38 | 0.0061 |
PT (%) | 89.8 ± 13.4 | 92.5 ± 11.4 | 87.8 ± 15.0 | 89.2 ± 13.5 | 0.254 |
Serum TBIL (mg/dL) | 0.78 ± 0.34 | 0.74 ± 0.32 | 0.79 ± 0.33 | 0.81 ± 0.39 | 0.777 |
ICGR15 | 14.2 (8.4-18.5) | 12.1 (8.1-15.4) | 14.7 (8.4-21.5) | 15.6 (13.0-24.6) | 0.163 |
AFP (ng/mL) | 18.6 (5.6-134.0) | 5.3 (3.8-11.0) | 21.1 (6.9-99.2) | 299.7 (68.1-1046.0) | < 0.0011 |
DCP (mAU/mL) | 45 (21-244) | 22 (15-35) | 37 (23-134) | 429 (124-1902) | < 0.0011 |
Intraoperative data | |||||
Blood loss (mL) | 330 (20-650) | 263 (70-500) | 230 (20-500) | 535 (300-1270) | 0.0061 |
Surgical duration (min) | 304 (230-377) | 303 (175-377) | 296 (230-352) | 345 (282-475) | 0.0401 |
Blood transfusion | |||||
RCC: yes/no (%) | 12/88 (12.0%) | 3/31 (8.8%) | 2/37 (5.1%) | 7/20 (25.9%) | 0.0301 |
Pathologic results | |||||
Tumor size (cm) | 3.51 ± 2.48 | 2.84 ± 1.23 | 3.26 ± 2.31 | 4.72 ± 3.39 | 0.0081 |
Multiple tumor: yes/no (%) | 36/64 (36.0%) | 8/26 (23.5%) | 17/22 (43.6%) | 11/16 (40.7%) | 0.171 |
Vascular invasion: yes/no (%) | 30/70 (30.0%) | 5/29 (14.7%) | 12/27 (30.8%) | 13/14 (48.1%) | 0.0181 |
Remnant liver: NL/CH/LC | 5/37/58 | 2/18/14 | 2027/10/2 | 2017/9/1 | 0.161 |
Histological tumor differentiation | |||||
Well/Moderately/Poorly | 17/63/20 | 7/23/4 | 8/24/7 | 2/16/9 | 0.213 |
Recurrence within 2 yr after hepatectomy | |||||
Yes/no (%) | 51/49 (51.0%) |
- Citation: Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients. World J Gastroenterol 2015; 21(16): 4933-4945
- URL: https://www.wjgnet.com/1007-9327/full/v21/i16/4933.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i16.4933